RECRUITING

Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Amblyopia and strabismus are characterized by a reduction in visual acuity, contrast sensitivity, grating acuity, vernier acuity, reading difficulties and binocular visual function deficits. Treated patients have residual visual function deficits. The purpose of the current study is to quantify various visual functions in amblyopic and strabismic participants at baseline, during and at the completion of treatment.

Official Title

Oculomotor Disorders: Experimental and Clinical Study

Quick Facts

Study Start:2020-02-21
Study Completion:2025-03-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04310241

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:6 Months to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * History of amblyopia or presence of amblyogenic risk factors.
  1. * History of neurologic disorders

Contacts and Locations

Study Contact

Kimberly Baynes, MSN
CONTACT
216-444-2566
baynesk@ccf.org

Principal Investigator

Fatema Ghasia, MD
PRINCIPAL_INVESTIGATOR
The Cleveland Clinic

Study Locations (Sites)

Cleveland Clinic
Cleveland, Ohio, 44195
United States

Collaborators and Investigators

Sponsor: The Cleveland Clinic

  • Fatema Ghasia, MD, PRINCIPAL_INVESTIGATOR, The Cleveland Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-02-21
Study Completion Date2025-03-12

Study Record Updates

Study Start Date2020-02-21
Study Completion Date2025-03-12

Terms related to this study

Additional Relevant MeSH Terms

  • Amblyopia
  • Strabismus